The association between autoimmune thyroiditis, autoimmune gastritis and type 1 diabetes

Pediatric Endocrinology Reviews

Volumn 1, Issue 1, 2003, Pages 21-37

  Lam Tse, Wai Kwan ^a   Batstra, Manou R ^b   Koeleman, Bobby P C ^c   Roep, Bart O ^c   Bruining, Mu G J ^d   Aanstoot, Henk Jan ^a   Drexhage, Hemmo A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b REINIER DE GRAAF HOSPITAL   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Auto antibodies; Autoimmune polyendocrine syndrome; Diabetes; Gastritis; Thyroiditis

Indexed keywords

IODINE; THYROXINE;

AUTOIMMUNE DISEASE; AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 3; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; GASTRITIS; GENETIC POLYMORPHISM; HASHIMOTO DISEASE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; REVIEW; ANIMAL; AUTOIMMUNE THYROIDITIS; IMMUNOLOGY;

ANIMALS; DIABETES MELLITUS, TYPE 1; GASTRITIS; HUMANS; THYROIDITIS, AUTOIMMUNE;

EID: 0141554924     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (155)

1. Neufeld M, Maclaren N, Blizzard R. Autoimmune polyglandular syndromes. Pediatr Ann 1980:9:154-62
2. Betterle C, Dal Pra C, Mantero F, Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 2002:23:327-64
3. Muir A, She JX. Advances in the genetics and immunology of autoimmune polyglandular syndrome II/III and their clinical applications. Ann Med Interne (Paris) 1999:150:301-12
4. Fernandez-Castaner M, Molina A, Lopez-Jimenez L, Gomez JM, Soler J. Clinical presentation and early course of type 1 diabetes in patients with and without thyroid autoimmunity. Diabetes Care 1999:22:377-81
5. Maugendre D, Sonnet E, Derrien C, Le Golff MC, Grais MC, Allannic H, Delamaire M. Combined analysis of long-term anti-beta-cell humoral reactivity in type 1 diabetes with and without thyroid disease. Diabetes Metab 1999:25:28-33
6. De Block CE, De Leeuw IH, Vertommen JJ, Rooman RP, Du Caju MV, Van Campenhout CM, Weyler JJ, Winnock F, Van Autreve J, Gorus FK. Beta-cell, thyroid, gastric, adrenal and coeliac autoimmunity and HLA- DQ types in type 1 diabetes. Clin Exp Immunol 2001:126:236-41
7. Maugendre D, Massart C, Karacatsanis C, Guilhem I, Poirier JY, Sonnet E, Allannic H. Increased prevalence of thyroid autoantibodies and subclinical thyroid failure in relatives of patients with overt endocrine disease- associated diabetes but not type 1 diabetes alone. Diabetes Metab 1997:23:302-7
8. Holl RW, Bohm B, Loos U, Grabert M, Heinze E, Homoki J. Thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus. Effect of age, gender and HLA type. Horm Res 1999:52:113-8.
9. Hansen D, Bennedbaek FN, Hansen LK, Hoier-Madsen M, Jacobsen BB, Hegedus L. Thyroid function, morphology and autoimmunity in young patients with insulin-dependent diabetes mellitus. Eur J Endocrinol 1999:140:512-8
10. De Block C, De Leeuw I. Associated thyrogastric autoimmunity increases the prevalence of low erythrocyte magnesium in type 1 diabetes. Magnes Res 1999:12:279-85
11. Kordonouri O, Deiss D, Danne T, Dorow A, Bassir C, Gruters-Kieslich A. Predictivity of thyroid autoantibodies for the development of thyroid disorders in children and adolescents with Type 1 diabetes. Diabet Med 2002:19:518-21
12. Maclaren NK, Riley WJ. Thyroid, gastric, and adrenal autoimmunities associated with insulin- dependent diabetes mellitus. Diabetes Care 1985:8(Suppl 1):34-8
13. Kordonouri O, Klinghammer A, Lang EB, Gruters-Kieslich A, Grabert M, Holl RW. Thyroid autoimmunity in children and adolescents with type 1 diabetes: a multicenter survey. Diabetes Care 2002:25:1346-50
14. Betterle C, Zanette F, Pedini B, Presotto F, Rapp LB, Monciotti CM, Rigon F. Clinical and subclinical organ-specific autoimmune manifestations in type 1 (insulin-dependent) diabetic patients and their first-degree relatives. Diabetologia 1984:26:431-6
15. De Block CE, De Leeuw IH, Decochez K, Winnock F, Van Autreve J, Van Campenhout CM, Martin M, Gorus FK. The presence of thyrogastric antibodies in first degree relatives of type 1 diabetic patients is associated with age and proband antibody status. J Clin Endocrinol Metab 2001:86:4358-63
16. Franzese A, Buono P, Mascolo M, Leo AL, Valerio G. Thyroid autoimmunity starting during the course of type 1 diabetes denotes a subgroup of children with more severe diabetes. Diabetes Care 2000:23:1201-2
17. Leong KS, Wallymahmed M, Wilding J, MacFarlane I. Clinical presentation of thyroid dysfunction and Addison's disease in young adults with type 1 diabetes. Postgrad Med J 1999:75:467-70
18. Lorini R, d'Annunzio G, Vitali L, Scaramuzza A. IDDM and autoimmune thyroid disease in the pediatric age group. J Pediatr Endocrinol Metab 1996:9(Suppl 1):89-94
19. Roldan MB, Alonso M, Barrio R. Thyroid autoimmunity in children and adolescents with Type 1 diabetes mellitus. Diabetes Nutr Metab 1999:12:27-31
20. Prina Cerai LM, Weber G, Meschi F, Mora S, Bognetti E, Siragusa V, di Natale B. Prevalence of thyroid autoantibodies and thyroid autoimmune disease in diabetic children and adolescents. Diabetes Care 1994:17:782-3
21. McKenna MJ, Herskowitz R, Wolfsdorf JI. Screening for thyroid disease in children with IDDM. Diabetes Care 1990:13:801-3
22. Radetti G, Paganini C, Gentili L, Bernasconi S, Betterle C, Borkenstein M, Cvijovic K, Kadrnka-Lovrencic M, Krzisnik C, Battelino T, et al. Frequency of Hashimoto's thyroiditis in children with type 1 diabetes mellitus. Acta Diabetol 1995:32:121-4
23. Fernandez-Soto L, Gonzalez A, Lobon JA, Lopez JA, Peterson CM, Escobar-Jimenez F. Thyroid peroxfdase autoantibodies predict poor metabolic control and need for thyroid treatment in pregnant IDDM women. Diabetes Care 1997:20:1524-8
24. McCanlies E, O'Leary LA, Foley TP, Kramer MK, Burke JP, Libman A, Swan JS, Steenkiste AR, McCarthy BJ, Trucco M, Dprman JS. Hashimoto's thyroiditis and insulin-dependent diabetes mellitus: differences among individuals with and without abnormal thyroid function. J Clin Endocrinol Metab 1998:83:1548-51
25. Gambelunghe G, Forini F, Laureti S, Murdolo G, Toraldo G, Santeusanio F, Brunetti P, Sanjeevi CB, Falorni A. Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies. Clin Endocrinol (Oxf) 2000:52:565-73
26. Falorni A, Gambelunghe G, Forini F, Kassi G, Cosentino A, Candeloro P, Bolli GB, Brunetti P, Calcinaro F. Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the risk for insulin requirement in adult-onset diabetes mellitus. J Clin Endocrinol Metab 2000:85:309-16
27. Lohmann T, Kellner K, Verlphren HJ, Krug J, Steindorf J, Scherbaum WA, Seissler J. Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA). Diabetologia 2001:44:1005-10.
28. Tuomi T, Carlsson A, Li H, Isomaa B, Miettinen A, Nilsson A, Nissen M, Ehrnstrom BO, Forsen B, Snickars B, Lahti K, Forsblom C, Saloranta C, Taskinen MR, Groop LC. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 1999:48:150-7
29. Kawasaki E, Abiru N, Yano M, Uotani S, Matsumoto K, Matsuo H, Yamasaki H, Yamamoto H, Yamaguchi Y, Akazawa S, et al. Autoantibodies to glutamic acid decarboxylase in patients with autoimmune thyroid disease: relation to competitive insulin autoantibodies. J Autoimmun 1995:8:633-43
30. Yamaguchi Y, Chikuba N, Ueda Y, Yamamoto H, Yamasaki H, Nakanishi T, Akazawa S, Nagataki S. Islet cell antibodies in patients with autoimmune thyroid disease. Diabetes 1991:40:319-22
31. Pietropaolo M, Peakman M, Pietropaolo SL, Zanone MM, Foley TP, Jr., Becker DJ, Trucco M. Combined analysis of GAD65 and ICA512(IA-2) autoantibodies in organ and non-organ-specific autoimmune diseases confers high specificity for insulin-dependent diabetes mellitus. J Autoimmun 1998:11:1-10
32. Di Mario U, Perfetti R, Anastasi E, Contreas G, Crisa L, Tiberti C, Amendolea MA, Masala C. Autoantibodies to insulin do appear in non-diabetic patients with autoimmune disorders: comparison with anti-immunoglobulin antibodies and other autoimmune phenomena. Acta Endocrinol (Copenh) 1990:122:303-8
33. Nuovo JA, Baker JR, Jr., Wartofsky L, Lukes YG, Burman KD. Autoantibodies to insulin are present in sera of patients with autoimmune thyroid disease. Diabetes 1988:37:317-20
34. Williams AJ, Bingley PJ, Bonifacio E, Palmer JP, Gale EA. A novel micro-assay for insulin autoantibodies. J Autoimmun 1997:10:473-8
35. Betterle C, Presotto F, Pedini B, Moro L, Slack RS, Zanette F, Zanchetta R. Islet cell and insulin autoantibodies in organ-specific autoimmune patients. Their behaviour and predictive value for the development of type 1 (insulin-dependent) diabetes mellitus. A 10-year follow-up study. Diabetologia 1987:30:292-7
36. Bosi E, Becker F, Bonifacio E, Wagner R, Collins P, Gale EA, Bottazzo GF. Progression to type I diabetes in autoimmune endocrine patients with islet cell antibodies. Diabetes 1991:40:977-84
37. Rattarasarn C, Diosdado MA, Ortego J, Leelawattana R, Soonthornpun S, Setasuban W, Jaruratanasirikul S, Patarakijvanich N. Thyroid autoantibodies in Thai type 1 diabetic patients: clinical significance and their relationship with glutamic acid decarboxylase antibodies. Diabetes Res Clin Pract 2000:49:107-11
38. Kawasaki E, Takino H, Yano M, Uotani S, Matsumoto K, Takao Y, Yamaguchi Y, Akazawa S, Nagataki S. Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease. Diabetes 1994:43:80-6
39. Chang CC, Huang CN, Chuang LM. Autoantibodies to thyroid peroxidase in patients with type 1 diabetes in Taiwan. Eur J Endocrinol 1998:139:44-8
40. Chen BH, Chung SB, Chiang W, Chao MC. GAD65 antibody prevalence and association with thyroid antibodies, HLA- DR in Chinese children with type 1 diabetes mellitus. Diabetes Res Clin Pract 2001:54:27-32
41. Christie MR, Genovese S, Cassidy D, Bosi E, Brown TJ, Lai M, Bonifacio E, Bottazzo GF. Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity. Diabetes 1994:43:1254-9
42. Burek CL, Rose NR, Guire KE, Hoffman WH. Thyroid autoantibodies in black and in white children and adolescents with type 1 diabetes mellitus and their first degree relatives. Autoimmunity 1990:7:157-67
43. Fialkow PJ, Zavala C, Nielsen R. Thyroid autoimmunity: increased frequency in relatives of insulin-dependent diabetes patients. Ann Intern Med 1975:83:170-6
44. Takara M, Komiya I, Kinjo Y, Tomoyose T, Yamashiro S, Akamine H, Masuda M, Takasu N. Association of CTLA-4 gene A/G polymorphism in Japanese type 1 diabetic patients with younger age of onset and autoimmune thyroid disease. Diabetes Care 2000:23:975-8
45. Lindberg B, Ericsson UB, Ljung R, Ivarsson SA. High prevalence of thyroid autoantibodies at diagnosis of insulin- dependent diabetes mellitus in Swedish children. J Lab Clin Med 1997:130:585-9
46. Groop L, Miettinen A, Gropp PH, Meri S, Koskimies S, Bottazzo GF. Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes. Diabetes 1988:37:99-103
47. Djilali-Saiah I, Bertin E, Larger E, Timsit J, Assan R, Boitard C, Bach JF, Caillat-Zucman S. Major histocompatibility class II genes polymorphism in insulin dependent diabetes mellitus with or without associated thyroid autoimmunity. Hum Immunol 1998:59:176-82
48. Johnston C, Millward BA, Leslie RD, Pyke DA, Bottazzo GF. Are thyrogastric autoantibodies associated with an increased susceptibility to developing type 1 (insulin-dependent) diabetes? A study in identical twins. Autoimmunity 1990:6:195-201
49. Abrams P, De Leeuw I, Vertommen J. In new-onset insulin-dependent diabetic patients the presence of anti-thyroid peroxidase antibodies is associated with islet cell autoimmunity and the high risk haplotype HLA DQA1*0301-DQB1*0302. Belgian Diabetes Registry. Diabet Med 1996:13:415-9
50. Hagglof B, Rabinovitch A, Mackay P, Huen A, Rubenstein AH, Marner B, Nerup J, Lernmark A. Islet cell and other organ-specific autoantibodies in healthy first- degree relatives to insulin-dependent. Acta Paediatr Scand 1986:75:611-8.
51. Roman SH, Davies TF, Witt ME, Ginsberg-Fellner F, Rubinstein P. Thyroid autoantibodies in HLA-genotyped type 1 diabetic families: sex-limited DR5 association with thyroid microsomal antibody. Clin Endocrinol (Oxf) 1986:25:23-33
52. Van der Auwera BJ, Vandewalle CL, Schuit FC, Winnock F, De Leeuw IH, Van Imschoot S, Lamberigts G, Gorus FK. CTLA-4 gene polymorphism confers susceptibility to insulin-dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers. The Belgian Diabetes Registry. Clin Exp Immunol 1997:110:98-103
53. Nistico L, Buzzetti R, Pritchard LE, Van der Auwera B, Giovannini C, Bosi E, Larrad MT, Rios MS, Chow CC, Cockram CS, Jacobs K, Mijovic C, Bain SC, Barnett AH, Vandewalle CL, Schuit F, Gorus FK, Tosi R, Pozzilli P, Todd JA. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum Mol Genet 1996:5:1075-80
54. Vaidya B, Imrie H, Perros P, Young ET, Kelly WF, Carr D, Large DM, Toft AD, McCarthy MI, Kendall-Taylor P, Pearce SH. The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus. Hum Mol Genet 1999:8:1195-9
55. Djilali-Saiah I, Larger E, Harfouch-Hammoud E, Timsit J, Clerc J, Bertin E, Assan R, Boitard C, Bach JF, Caillat-Zucman S. No major role for the CTLA-4 gene in the association of autoimmune thyroid disease with IDDM. Diabetes 1998:47:125-7
56. Kristiansen OP, Larsen ZM, Pociot F. CTLA-4 in autoimmune diseases - a general susceptibility gene to autoimmunity? Genes Immun 2000:1:170-84
57. Uibo R, Krohn K, Villako K, Tammur R, Tamm A. Relation of parietal cell and thyroid antibodies to the state of gastric mucosa and basal serum gastrin levels during a 6-year follow up. Clin Exp Immunol 1989:77:202-5
58. Uibo R, Krohn K, Villako K, Tammur R, Tamm A. The relationship of parietal cell, gastrin cell, and thyroid autoantibodies to the state of the gastric mucosa in a population sample. Scand J Gastroenterol 1984:19:1075-80
59. Strickland RG. Gastritis. Springer Semin Immunopathol 1990:12:203-17
60. Kaye MD. Immunological aspects of gastritis and pernicious anaemia. Baillieres Clin Gastroenterol 1987:1:487-506
61. Cruchaud A, Juditz E. An analysis of gastric parietal cell antibodies and thyroid cell antibodies in patients with pernicious anaemia and thyroid disorders. Clin Exp Immunol 1968:3:771-81
62. Ottesen M, Feldt-Rasmussen U, Andersen J, Hippe E, Schouboe A. Thyroid function and autoimmunity in pernicious anemia before and during cyanocobalamin treatment. J Endocrinol Invest 1995:18:91-7
63. Centanni M, Marignani M, Gargano L, Corleto VD, Casini A, Delle Fave G, Andreoli M, Annibale B. Atrophic body gastritis in patients with autoimmune thyroid disease: an underdiagnosed association. Arch Intern Med 1999:159:1726-30
64. Elisei R, Mariotti S, Swillens S, Vassart G, Ludgate M. Studies with recombinant autoepitopes of thyroid peroxidase: evidence suggesting an epitope shared between the thyroid and the gastric parietal cell. Autoimmunity 1990:8:65-70
65. Wiersinga WM, Touber JL. The relation between gastrin, gastric acid and thyroid function disorders. Acta Endocrinol (Copenh) 1980:95:341-9
66. Fukao A, Takamatsu J, Shimamoto C, Kuma K, Ohsawa N. Persistently increased gastrin and decreased pepsinogen concentrations in serum from some patients with Graves' disease of triiodothyronine-predominant type and common type. Thyroid 1998:8:259-63
67. Dahlberg PA, Karlsson FA, Lundqvist G. High serum gastrin levels in thyrotoxic patients. Clin Endocrinol (Oxf) 1981:14:125-31
68. Ungar B, Mathews JD, Tait BD, Cowling DC. HLA-DR patterns in pernicious anaemia. Br Med J (Clin Res Ed) 1981:282:768-70
69. De Block CE, De Leeuw IH, Van Gaal LF. High prevalence of manifestations of gastric autoimmunity in parietal cell antibody-positive type 1 (insulin-dependent) diabetic patients. The Belgian Diabetes Registry. J Clin Endocrinol Metab 1999:84:4062-7
70. Jaeger C, Hatziagelaki E, Petzoldt R, Bretzel RG. Comparative analysis of organ-specific autoantibodies and celiac disease-associated antibodies in type 1 diabetic patients, their first- degree relatives, and healthy control subjects. Diabetes Care 2001:24:27-32
71. Lorini R, Larizza D, Livieri C, Cammareri V, Martini A, Plebani A, Zanaboni D, Severi F. Auto-immunity in children with diabetes mellitus and in their relatives. Eur J Pediatr 1986:145:182-4
72. Riley WJ, Toskes PP, Maclaren NK, Silverstein JH. Predictive value of gastric parietal cell autoantibodies as a marker for gastric and hematologic abnormalities associated with insulin-dependent diabetes. Diabetes 1982:31:1051-5
73. Kokkonen J. Parietal cell antibodies and gastric secretion in children with diabetes mellitus. Acta Paediatr Scand 1980:69:485-9
74. De Block CE, De Leeuw IH, Rooman RP, Winnock F, Du Caju MV, Van Gaal LF. Gastric parietal cell antibodies are associated with glutamic acid decarboxylase-65 antibodies and the HLA DQA1*0501-DQB1*0301 haplotype in Type 1 diabetes mellitus. Belgian Diabetes Registry. Diabet Med 2000:17:618-22
75. Sreekumar GP, Smyth JR, Jr., Ambady S, Ponce de Leon FA. Analysis of the effect of endogenous viral genes in the Smyth line chicken model for autoimmune vitiligo. Am J Pathol 2000:156:1099-107
76. Greiner DL, Rossini AA, Mordes JP. Translating data from animal models into methods for preventing human autoimmune diabetes mellitus: caveat emptor and primum non nocere. Clin Immunol 2001:100:134-43
77. Sternthal E, Like AA, Sarantis K, Braverman LE. Lymphocytic thyroiditis and diabetes in the BB/W rat. A new model of autoimmune endocrinopathy. Diabetes 1981:30:1058-61.
78. Mooij P, de Wit HJ, Drexhage HA. An excess of dietary iodine accelerates the development of a thyroid-associated lymphoid tissue in autoimmune prone BB rats. Clin Immunol Immunopathol 1993:69:189-98
79. Allen EM. Acute iodine ingestion increases intrathyroidal glutathione. J Endocrinol Invest 1993:16:265-70
80. Allen EM, Appel MC, Braverman LE. Iodine-induced thyroiditis and hypothyroidism in the hemithyroidectomized BB/W rat. Endocrinology 1987:121:481-5
81. MacMurray AJ, Moralejo DH, Kwitek AE, Rutledge EA, Van Yserloo B, Gohlke P, Speros SJ, Snyder B, Schaefer J, Bieg S, Jiang J, Ettinger RA, Fuller J, Daniels TL, Pettersson A, Orlebeke K, Birren B, Jacob HJ, Lander ES, Lernmark A. Lymphopenia in the BB Rat Model of Type 1 Diabetes is Due to a Mutation in a Novel Immune-Associated Nucleotide (Ian)-Related Gene. Genome Res 2002:12:1029-39
82. Pettersson A, Wilson D, Daniels T, Tobin S, Jacob HJ, Lander ES, Lernmark A. Thyroiditis in the BB rat is associated with lymphopenia but occurs independently of diabetes. J Autoimmun 1995:8:493-505
83. Greiner DL, Handler ES, Nakano K, Mordes JP, Rossini AA. Absence of the RT-6 T cell subset in diabetes-prone BB/W rats. J Immunol 1986:136:148-51
84. Leiter EH, Serreze DV, Prochazka M. The genetics and epidemiology of diabetes in NOD mice. Immunol Today 1990:11:147-9
85. Myers MA, Laks MR, Feeney SJ, Mandel TE, Koulmanda M, Bone A, Barley J, Rowley MJ, Mackay IR. Antibodies to ICA512/IA-2 in rodent models of IDDM. J Autoimmun 1998:11:265-72
86. Bonifacio E, Atkinson M, Eisenbarth G, Serreze D, Kay TW, Lee-Chan E, Singh B. International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice. Diabetes 2001:50:2451-8
87. Cheta D. Animal models of type I (insulin-dependent) diabetes mellitus. J Pediatr Endocrinol Metab 1998:11:11-9
88. McDuffie M. Genetics of autoimmune diabetes in animal models. Curr Opin Immunol 1998:10:704-9
89. Boulard O, Fluteau G, Eloy L, Damotte D, Bedossa P, Garchon HJ. Genetic analysis of autoimmune sialadenitis in nonobese diabetic mice: a major susceptibility region on chromosome 1. J Immunol 2002:168:4192-201
90. Brayer J, Lowry J, Cha S, Robinson CP, Yamachika S, Peck AB, Humphreys-Bener MG. Alleles from chromosomes 1 and 3 of NOD mice combine to influence Sjogren's syndrome-like autoimmune exocrinopathy. J Rheumatol 2000:27:1896-904
91. Rasooly L, Burek CL, Rose NR. Iodine-induced autoimmune thyroiditis in NOD-H-2h4 mice. Clin Immunol Immunopathol 1996:81:287-92
92. Many MC, Maniratunga S, Denef JF. The non-obese diabetic (NOD) mouse: an animal model for autoimmune thyroiditis. Exp Clin Endocrinol Diabetes 1996:104(Suppl 3):17-20
93. Ruwhof C, Drexhage HA. Iodine and thyroid autoimmune disease in animal models. Thyroid 2001:11:427-36
94. Dietrich HM, Cole RK, Wick G. The natural history of the obese strain of chickens - an animal model for spontaneous autoimmune thyroiditis. Poult Sci 1999:78:1359-71
95. Cole RK. Hereditary hypothyroidism in the domestic fowl. Genetics 1966:53:1021-33
96. Vasicek D, Vasickova K, Kaiser P, Drozenova R, Citek J, Hala K. Analysis of genetic regulation of chicken spontaneous autoimmune thyroiditis, an animal model of human Hashimoto's thyroiditis. Immunogenetics 2001:53:776-85
97. Sundick RS, Bagchi N, Brown TR. The obese strain chicken as a model for human Hashimoto's thyroiditis. Exp Clin Endocrinol Diabetes 1996:104(Suppl 3):4-6
98. Wick G, Sgonc R, Lechner O. Neuroendocrine-immune disturbances in animal models with spontaneous autoimmune diseases. Ann N Y Acad Sci 1998:840:591-8
99. Sacerdote P, Lechner O, Sidman C, Wick G, Panerai AE. Hypothalamic beta-endorphin concentrations are decreased in animal models of autoimmune disease. Ann N Y Acad Sci 1999:876:305-8
100. Taguchi O, Nishizuka Y. Autoimmune oophoritis in thymectomized mice: T cell requirement in adoptive cell transfer. Clin Exp Immunol 1980:42:324-31
101. Sakaguchi S, Takahashi T, Nishizuka Y. Study on cellular events in postthymectomy autoimmune oophoritis in mice. I. Requirement of Lyt-1 effector cells for oocytes damage after adoptive transfer. J Exp Med 1982:156:1565-76
102. Alderuccio F, Sentry JW, Marshall AC, Biondo M, Toh BH. Animal models of human disease: experimental autoimmune gastritis - a model for autoimmune gastritis and pernicious anemia. Clin Immunol 2002:102:48-58
103. Smith H, Sakamoto Y, Kasai K, Tung KS. Effector and regulatory cells in autoimmune oophoritis elicited by neonatal thymectomy. J Immunol 1991:147:2928-33
104. Tung KS, Smith S, Matzner P, Kasai K, Oliver J, Feuchter F, Anderson RE. Murine autoimmune oophoritis, epididymoorchitis, and gastritis induced by day 3 thymectomy. Autoantibodies. Am J Pathol 1987:126:303-14
105. Laurie KL, Van Driel IR, Gleeson PA. The role of CD4+CD25+ immunoregulatory T cells in the induction of autoimmune gastritis. Immunol Cell Biol 2002:80:567-73
106. McHugh RS, Shevach EM, Thornton AM. Control of organ-specific autoimmunity by immunoregulatory CD4(+)CD25(+) T cells. Microbes Infect 2001:3:919-27
107. Chatenoud L, Salomon B, Bluestone JA. Suppressor T cells - they're back and critical for regulation of autoimmunity! Immunol Rev 2001:182:149-63
108. Dharnidharka VR, Van Patten Y, Bahjat FR, Clare-Salzler M. Fas stimulation results in selective islet infiltrate apoptosis in situ and reversal of diabetes. Ann N Y Acad Sci 2002:958:160-2
109. Simons PJ, Delemarre FG, Drexhage HA. A functional and phenotypic study on immune accessory cells isolated from the thyroids of Wistar and autoimmune-prone BB-DP rats. J Autoimmun 2000:15:417-24
110. Delemarre FG, Simons PJ, de Heer HJ, Drexhage HA. Signs of immaturity of splenic dendritic cells from the autoimmune prone biobreeding rat: consequences for the in vitro expansion of regulator and effector T cells. J Immunol 1999:162:1795-801
111. Voorbij HA, Jeucken PH, Kabel PJ, De Haan M, Drexhage HA. Dendritic cells and scavenger macrophages in pancreatic islets of prediabetic BB rats. Diabetes 1989:38:1623-9
112. Ziegler AG, Erhard J, Lampeter EF, Nagelkerken LM, Standl E. Involvement of dendritic cells in early insulitis of BB rats. J Autoimmun 1992:5:571-9
113. Rosmalen JG, Homo-Delarche F, Durant S, Kap M, Leenen PJ, Drexhage HA. Islet abnormalities associated with an early influx of dendritic cells and macrophages in NOD and NODscid mice. Lab Invest 2000:80:769-77
114. Simons PJ, Delemarre FG, Jeucken PH, Drexhage HA. Pre-autoimmune thyroid abnormalities in the biobreeding diabetes-prone (BB-DP) rat: a possible relation with the intrathyroid accumulation of dendritic cells and the initiation of the thyroid autoimmune response. J Endocrinol 1998:157:43-51
115. Serreze DV, Fleming SA, Chapman HD, Richard SD, Leiter EH, Tisch RM. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Immunol 1998:161:3912-8
116. Martin S, Wolf-Eichbaum D, Duinkerken G, Scherbaum WA, Kolb H, Noordzij JG, Roep BO. Development of type 1 diabetes despite severe hereditary B-lymphocyte deficiency. N Engl J Med 2001:345:1036-40
117. Brown TR, Zhao G, Palmer KC, Sundick RS. Thyroid injury, autoantigen availability, and the initiation of autoimmune thyroiditis. Autoimmunity 1998:27:1-12
118. Reinhardt W, Luster M, Rudorff KH, Heckmann C, Petrasch S, Lederbogen S, Haase R, Saller B, Reiners C, Reinwein D, Mann K. Effect of small doses of iodine on thyroid function in patients with Hashimoto's thyroiditis residing in an area of mild iodine deficiency. Eur J Endocrinol 1998:139:23-8
119. Martino E, Aghini-Lombardi F, Bartalena L, Grasso L, Loviselli A, Velluzzi F, Pinchera A, Braverman LE. Enhanced susceptibility to amiodarone-induced hypothyroidism in patients with thyroid autoimmune disease. Arch Intern Med 1994:154:2722-6
120. Roti E, Minelli R, Gardini E, Bianconi L, Braverman LE. Iodine-induced hypothyroidism in euthyroid subjects with a previous episode of subacute thyroiditis. J Clin Endocrinol Metab 1990:70:1581-5
121. Vauhkonen I, Niskanen L, Knip M, Ilonen J, Vanninen E, Kainulainen S, Uusitupa M, Laakso M. Impaired insulin secretion in non-diabetic offspring of probands with latent autoimmune diabetes mellitus in adults. Diabetologia 2000:43:69-78
122. Lindgren FA, Hartling SG, Dahlquist GG, Binder C, Efendic S, Persson BE. Glucose-induced insulin response is reduced and proinsulin response increased in healthy siblings of type 1 diabetic patients. Diabet Med 1991:8:638-43
123. Juneja R, Hirsch IB, Naik RG, Brooks-Worrell BM, Greenbaum CJ, Palmer JP. Islet cell antibodies and glutamic acid decarboxylase antibodies, but not the clinical phenotype, help to identify type 1(1/2) diabetes in patients presenting with type 2 diabetes. Metabolism 2001:50:1008-13
124. Jongbloet PH, Groenewoud HM, Hirasing RA, Van Buuren S. Seasonality of birth in patients with childhood diabetes in The Netherlands. Diabetes Care 1998:21:190-1.
125. Kordonouri O, Shuga N, Lewy H, Ashkenazi I, Laron Z. Seasonality of month of birth of children and adolescents with type 1 diabetes mellitus in Berlin differs from the general population. Eur J Pediatr 2002:161:291-2
126. Laron Z. Interplay between heredity and environment in the recent explosion of type 1 childhood diabetes mellitus. Am J Med Genet 2002:115:4-7
127. McKinney PA. Seasonality of birth in patients with childhood Type I diabetes in 19 European regions. Diabetologia 2001:44(Suppl 3):B67-74
128. Rothwell PM, Gutnikov SA, McKinney PA, Schober E, Ionescu-Tirgoviste C, Neu A. Seasonality of birth in children with diabetes in Europe: multicentre cohort study. European Diabetes Study Group. Bmj 1999:319:887-8
129. Zhao H, Demaine AG, Millward BA. Seasonality of birth in children with diabetes. Results of various studies differ. Bmj 2000:320:716
130. Salminen K, Sadeharju K, Lonnrot M, Vahasalo P, Kupila A, Korhonen S, Ilonen J, Simell O, Knip M, Hyoty H. Enterovirus infections are associated with the induction of beta-cell autoimmunity in a prospective birth cohort study. J Med Virol 2003:69:91-8
131. Lonnrot M, Korpela K, Knip M, Ilonen J, Simell O, Korhonen S, Savola K, Muona P, Simell T, Koskela P, Hyoty H. Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: the Finnish Diabetes Prediction and Prevention Study. Diabetes 2000:49:1314-8
132. Hyoty H, Taylor KW. The role of viruses in human diabetes. Diabetologia 2002:45:1353-61
133. Honeyman MC, Coulson BS, Stone NL, Gellert SA, Goldwater PN, Steele CE, Couper JJ, Tait BD, Colman PG, Harrison LC. Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Diabetes 2000:49:1319-24
134. Muntoni S, Karvonen M, Tuomilehto J. Seasonality of birth in patients with type 1 diabetes. Lancet 2002:359:1246; discussion 1247-8
135. Mathieu C, van Etten E, Gysemans C, Decallonne B, Bouillon R. Seasonality of birth in patients with type 1 diabetes. Lancet 2002:359:1248
136. Facciani JM, Kazim M. Absence of seasonal variation in Graves disease. Ophthal Plast Reconstr Surg 2000:16:67-71
137. Westphal SA. Seasonal variation in the diagnosis of Graves' disease. Clin Endocrinol (Oxf) 1994:41:27-30
138. Uibo R, Vorobjova T, Metskula K, Kisand K, Wadstrom T, Kivik T. Association of Helicobacter pylori and gastric autoimmunity: a population-based study. FEMS Immunol Med Microbiol 1995:11:65-8
139. De Block CE, De Leeuw IH, Bogers JJ, Pelckmans PA, Ieven MM, Van Marck EA, Van Acker KL, Van Gaal LF. Autoimmune gastropathy in type 1 diabetic patients with parietal cell antibodies: histological and clinical findings. Diabetes Care 2003:26:82-8
140. Volpe R. Immunoregulation in autoimmune thyroid disease. Thyroid 1994:4:373-7.
141. Petersen LD, Duinkerken G, Bruining GJ, van Lier RA, de Vries RR, Roep BO. Increased numbers of in vivo activated T cells in patients with recent onset insulin-dependent diabetes mellitus. J Autoimmun 1996:9:731-7
142. Peterson LD, van der Keur M, de Vries RR, Roep BO. Autoreactive and immunoregulatory T-cell subsets in insulin-dependent diabetes mellitus. Diabetologia 1999:42:443-9
143. DeFranco S, Bonissoni S, Cerutti F, Bona G, Bottarel F, Cadario F, Brusco A, Loffredo G, Rabbone I, Cornas A, Pignata C, Ramenghi U, Dianzani U. Defective function of Fas in patients with type 1 diabetes associated with other autoimmune diseases. Diabetes 2001:50:483-8
144. Takahashi K, Honeyman MC, Harrison LC. Impaired yield, phenotype, and function of monocyte-derived dendritic cells in humans at risk for insulin-dependent diabetes. J Immunol 1998:161:2629-35
145. Jansen A, van Hagen M, Drexhage HA. Defective maturation and function of antigen-presenting cells in type 1 diabetes. Lancet 1995:345:491-2
146. Kupka RW, Nolen WA, Post RM, McElroy SL, Altshuler LL, Denicoff KD, Frye MA, Keck PE, Jr., Leverich GS, Rush AJ, Suppes T, Pollio C, Drexhage HA. High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure. Biol Psychiatry 2002:51:305-11
147. Reul JM, Holsboer F. Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr Opin Pharmacol 2002:2:23-33
148. De Kloet ER, Vreugdenhil E, Oitzl MS, Joels M. Brain corticosteroid receptor balance in health and disease. Endocr Rev 1998:19:269-301
149. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 2000:132:270-8
150. Shiau MY, Tsai ST, Hwang J, Wu CY, Chang YH. Relationship between autoantibodies against glutamic acid decarboxylase, thyroglobulin/thyroid microsome and DNA topoisomerase II in the clinical manifestation of patients with type 1 diabetes mellitus in Taiwan. Eur J Endocrinol 2000:142:577-85
151. Sjoberg K, Wassmuth R, Reichstetter S, Eriksson KF, Ericsson UB, Eriksson S. Gliadin antibodies in adult insulin-dependent diabetes-autoimmune and immunogenetic correlates. Autoimmunity 2000:32:217-28.
152. Landin-Olsson M, Karlsson FA, Lernmark A, Sundkvist G. Islet cell and thyrogastric antibodies in 633 consecutive 15- to 34-yr- old patients in the diabetes incidence study in Sweden. Diabetes 1992:41:1022-7
153. Hallengren B, Falorni A, Landin-Olsson M, Lernmark A, Papadopoulos KI, Sundkvist G. Islet cell and glutamic acid decarboxylase antibodies in hyperthyroid patients: at diagnosis and following treatment. J Intern Med 1996:239:63-8
154. Breunis MN, Kupka RW, Nolen WA, Suppes T, Denicoff KD, Leverich GS, Post RM, Drexhage HA. High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder. Biol Psychiatry 2002;52 (in press)
155. Irvine WJ. The association of atrophic gastritis with autoimmune thyroid disease. Clin Endocrinol Metab 1975;5:351-377